menu
    • menu

    Company profile for Emtora Biosciences

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Emtora Biosciences is an emerging life science company developing a novel formulation of rapamycin, eRapa™, for use in preventing the onset and recurrence of cancer. eRapa™ was originally developed for use in aging studies by Dr. Z. David Sharp and Dr. Randy Strong at the Barshop Institute for Longevity and Aging Studies at UT Health San Antonio in 2009. Their work uncovered numerous potential uses for eRapa™ in the f...
    Emtora Biosciences is an emerging life science company developing a novel formulation of rapamycin, eRapa™, for use in preventing the onset and recurrence of cancer. eRapa™ was originally developed for use in aging studies by Dr. Z. David Sharp and Dr. Randy Strong at the Barshop Institute for Longevity and Aging Studies at UT Health San Antonio in 2009. Their work uncovered numerous potential uses for eRapa™ in the fields of oncology, immunology, neurology, and trauma. eRapa™ is the only pharmaceutical agent to demonstrate significantly increased health span and lifespan in rodent models.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Emtora BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    16601 Blanco Rd. Suite #120, San Antonio, TX 78232
    Telephone
    Telephone
    (210) 381-2486
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://emtorabio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biodexa activates first site for Phase 3 Serenta trial in FAP
    Biodexa activates first site for Phase 3 Serenta trial in FAP

    25 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/25/3105070/0/en/Biodexa-Announces-Activation-of-First-Clinical-Study-Site-for-Phase-3-Serenta-Trial-in-Familial-Adenomatous-Polyposis-FAP.html

    GLOBENEWSWIRE
    25 Jun 2025
    Share Share
    Emtora Data Podium at DDW 2024
    Emtora Data Podium at DDW 2024

    30 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240430697501/en

    BUSINESSWIRE
    30 Apr 2024
    Share Share
    Emtora Biosciences Receives $16.9M Grant from the Cancer Prevention
    Emtora Biosciences Receives $16.9M Grant from the Cancer Prevention

    20 Aug 2022

    // FINSMES

    https://www.finsmes.com/2022/08/emtora-biosciences-receives-16-9m-grant.html

    FINSMES
    20 Aug 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search